Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies
about
Calcitonin gene-related peptide (CGRP) and migraineCalcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cellsToxin yet not toxic: Botulinum toxin in dentistryEvidence-based treatments for cluster headacheThe Neuropharmacology of Cluster Headache and other Trigeminal Autonomic CephalalgiasCurrent Understanding on Pain Mechanism in Migraine and Cluster HeadacheIncrease in meningeal blood flow by nitric oxide--interaction with calcitonin gene-related peptide receptor and prostaglandin synthesis inhibitionImmunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculatureCGRP may play a causative role in migraineNeuropeptides in migraine and cluster headacheTonabersat (SB-220453) a novel benzopyran with anticonvulsant properties attenuates trigeminal nerve-induced neurovascular reflexesA Potential Preclinical Migraine Model: CGRP-Sensitized Mice.Role of calcitonin gene-related peptide in light-aversive behavior: implications for migraine.Involvement of nitric oxide in the modulation of dural arterial blood flow in the rat.Capsaicin-sensitive neurogenic sensory vasodilatation in the dura mater of the rat.A review of diagnostic and functional imaging in headacheNoxious chemical stimulation of rat facial mucosa increases intracranial blood flow through a trigemino-parasympathetic reflex--an experimental model for vascular dysfunctions in cluster headache.Efficacy of oxygen inhalation in sumatriptan refractory "high altitude" cluster headache attacks.The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation.Secondary cluster headache responsive to sumatriptan.Headache-type adverse effects of NO donors: vasodilation and beyondCluster headache: new perspectives.The neurobiology of migraine.Diencephalic and brainstem mechanisms in migraine.Neuroimaging in headache.The 'headache tree' via umbellulone and TRPA1 activates the trigeminovascular system.Sensory nerves in man and their role in primary headaches.A translational in vivo model of trigeminal autonomic cephalalgias: therapeutic characterization.Trigeminal autonomic cephalgias.Role of trigeminal microvascular decompression in the treatment of SUNCT and SUNA.Tumor necrosis factor-alpha stimulation of calcitonin gene-related peptide expression and secretion from rat trigeminal ganglion neuronsNitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons.Pearls and pitfalls in experimental in vivo models of migraine: dural trigeminovascular nociception.Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the ratAcetylsalicylic acid inhibits cerebral cortical vasodilatation caused by superior sagittal sinus stimulation in the cat*.Effect of carbon dioxide on calcitonin gene-related peptide secretion from trigeminal neurons.Neurobiology of chronic tension-type headache.Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache.Vascular actions of calcitonin gene-related peptide and adrenomedullin.Release of PACAP-38 in episodic cluster headache patients - an exploratory study.
P2860
Q24633866-537CA050-8D4A-4579-AFF1-C08E1C1195A6Q24652416-FAB1ED90-C306-4BBC-A715-973D17B6AE4FQ26739891-8FD750B1-877B-4036-94FC-CA0B8A4721DCQ26774849-5F5C4229-E676-4AA0-9894-691799C85196Q26786375-6DD93C35-B4AC-4DB6-B197-E41F992C81FCQ28079173-BBDC883C-7B65-4730-83D2-C3C5D4819658Q28193135-BF2AFD80-6D06-4564-BBD9-7B211D6AB0BEQ28215715-A5C4750D-E219-4836-A060-F1E93CAF30C0Q28216666-A8C26C77-08BF-4219-8182-DADA6DE9FF12Q28305727-A3A155FF-4D16-4974-90CA-CC5C3EA5693AQ28361230-6796CE87-0620-4D5D-8D1D-147DB4943277Q30482553-B01AEB1F-1CE3-4138-BDE3-8CE432DDF387Q30496689-5EAFF39F-8C58-4F83-AF0F-3E6818247087Q30853246-A4B31E27-0B2F-460A-8AC0-7015C4CF105DQ30979297-24EBC4EA-032F-4462-85F2-5083AD408FFCQ31052635-3ADBE3DA-47E4-423C-83F4-17AD8507D302Q33199130-1B211D75-9945-4AB2-BF32-F11E44EDF6FEQ33443722-6DFF65DC-954A-4477-8CD5-E4EFDCA3C4ECQ33535327-4FDE26F3-11D1-4AFC-8248-2E01F6E24CD8Q33734855-7979FE14-C38E-4DD0-B9DA-7BBB16FABC68Q33812736-46EE2AB6-8CA6-4E8D-9E7A-747E35B10F40Q33833914-97FE6036-9BFB-4445-89E8-2DAA7DF99C56Q33864078-1FC21A45-0325-44D1-B90A-C33E414B1359Q34217686-488938AD-F4DC-4B7C-9CCA-2BB7A4527471Q34218319-5042A06C-D276-4DAB-972F-EA2B63BB0049Q34228530-EAA167AB-4D4C-4D34-B8B5-0C9C9B5D96E5Q34397671-ACCED13A-0580-446F-B4BA-8A95C54B3E35Q34445305-020835A6-1025-4147-988A-E52C141717B8Q34499937-AA152209-ADF4-4898-8313-01454BE8BFE1Q34657574-EF9E5ADF-93B3-417A-B59F-A0F90ACA957FQ34708824-9D8333E2-80BE-48CC-BC39-E49BBF352BAEQ34708829-D304BA08-1B62-4847-9AA5-6AE2546E1401Q34720188-0F0501CD-6DC6-432E-9FF2-5E6AA5E9E0B9Q35048367-203CC827-B565-41F4-9666-BA78A7BE6810Q35055534-AFAF3D50-1323-4642-94D2-F697C1CE72EAQ35110517-BFBB42FA-AB51-410D-8087-6FA70CCA9E00Q35685806-FBA539CF-916A-4782-8EC5-4E9DD17661A6Q35841612-E96C5B23-5384-450B-83E1-46C3883A4E79Q35842993-20293D16-2306-43CB-8852-B4C1B9599056Q36090751-ED5C1B96-81E4-4C81-B0A9-F7102C3BCC6C
P2860
Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Human in vivo evidence for tri ...... cts of acute attacks therapies
@ast
Human in vivo evidence for tri ...... cts of acute attacks therapies
@en
Human in vivo evidence for tri ...... cts of acute attacks therapies
@nl
type
label
Human in vivo evidence for tri ...... cts of acute attacks therapies
@ast
Human in vivo evidence for tri ...... cts of acute attacks therapies
@en
Human in vivo evidence for tri ...... cts of acute attacks therapies
@nl
prefLabel
Human in vivo evidence for tri ...... cts of acute attacks therapies
@ast
Human in vivo evidence for tri ...... cts of acute attacks therapies
@en
Human in vivo evidence for tri ...... cts of acute attacks therapies
@nl
P3181
P356
P1433
P1476
Human in vivo evidence for tri ...... cts of acute attacks therapies
@en
P304
P3181
P356
10.1093/BRAIN/117.3.427
P407
P478
117 ( Pt 3)
P577
1994-06-01T00:00:00Z